Boston Scientific Corporation
BSX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,846,000 | $1,592,000 | $698,000 | $1,041,000 |
| Dep. & Amort. | $1,269,000 | $1,196,000 | $1,136,000 | $1,093,000 |
| Deferred Tax | $0 | -$1,000 | -$63,000 | -$124,000 |
| Stock-Based Comp. | $266,000 | $233,000 | $220,000 | $194,000 |
| Change in WC | -$462,000 | -$770,000 | -$1,005,000 | -$351,000 |
| Other Non-Cash | $516,000 | $253,000 | $540,000 | $18,000 |
| Operating Cash Flow | $3,435,000 | $2,503,000 | $1,526,000 | $1,870,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$790,000 | -$711,000 | -$612,000 | -$554,000 |
| Net Acquisitions | -$4,640,000 | -$1,811,000 | -$1,537,000 | -$1,432,000 |
| Inv. Purchases | $0 | $0 | -$24,000 | $96,000 |
| Inv. Sales/Matur. | $0 | $0 | $56,000 | $294,000 |
| Other Inv. Act. | -$257,000 | -$52,000 | $106,000 | -$1,000 |
| Investing Cash Flow | -$5,687,000 | -$2,574,000 | -$2,011,000 | -$1,597,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,827,000 | -$4,000 | -$165,000 | $0 |
| Stock Issued | $230,000 | $182,000 | $0 | $110,000 |
| Stock Repurch. | $0 | $0 | $136,000 | $0 |
| Dividends Paid | $0 | -$28,000 | -$55,000 | -$55,000 |
| Other Fin. Act. | -$243,000 | -$145,000 | -$464,000 | -$150,000 |
| Financing Cash Flow | $1,814,000 | $5,000 | -$548,000 | -$95,000 |
| Forex Effect | -$11,000 | -$16,000 | -$9,000 | -$8,000 |
| Net Chg. in Cash | -$449,000 | -$82,000 | -$1,042,000 | $171,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,055,000 | $1,077,000 | $2,168,000 | $1,995,000 |
| End Cash | $606,000 | $995,000 | $1,126,000 | $2,168,000 |
| Free Cash Flow | $2,645,000 | $1,703,000 | $914,000 | $1,316,000 |